The Leukemia & Lymphoma Society (LLS) continues to lead cutting-edge research to advance treatments for myeloma and lymphoma. Adding to the momentum, the organization announced a $1,175,000 commitment by the Schwartz Ward Family Foundation (SWFF) of Chicago to support two unique research initiatives including a novel therapy for a rare form of lymphoma and an innovative immunotherapy approach for multiple myeloma.

MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced a clinical collaboration to evaluate the safety and efficacy of MEI's ME-401, an investigational PI3K delta inhibitor, in combination with BeiGene's zanubrutinib, an investigational BTK inhibitor, for the treatment of patients with B-cell malignancies.

Long-term care facilities play a critical role in caring for the needs of a growing aging population with a lengthening lifespan.

Agreement Establishes a New Stronghold in a Rapidly Expanding Fertility Market

Montefiore’s outstanding stroke care has been recognized by an Advanced Comprehensive Stroke Center designation, meaning that the highest standards of lifesaving stroke care are close to home for millions of New Yorkers.

Research shows adding Abbott's High Sensitive Troponin-I diagnostic test to doctors' existing standard of care can help more accurately determine a person's chances of a heart attack or other cardiac event potentially months to years in advance

AbbVie, a research-based global biopharmaceutical company, today announced a donation of $5 million to Family Reach to support the organization's efforts to alleviate the financial burden of cancer on pediatric patients and families across the United States.

Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Emgality™ (galcanezumab) for the prophylaxis of migraine in adults who have at least four migraine days per month.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra® (tocilizumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients two years of age and older.

Astrazeneca issued the following announcement on Sept. 13.AstraZeneca and MedImmune, its global biologics research and development arm, announced today that the US Food and Drug Administration (FDA) has approved LUMOXITI™ (moxetumomab pasudotox-tdfk) for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

Agreement Adds Continuous Glucose Data Fueling Diabetes Management Insights

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions

Ceterix® Orthopaedics, Inc., a leader in the development of cutting-edge surgical tools for orthopaedic surgeons, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an added feature to the NovoStitch® Pro Meniscal Repair System – a size 0 suture cartridge – offering surgeons more options to repair meniscal tears.

Landmark study is the first prospective, randomized study comparing the Convergent approach to endocardial catheter ablation in persistent and long-standing persistent atrial fibrillation patients

Massachusetts General Hospital (MGH) and ideas42, a nonprofit behavioral design lab, announced a new research collaboration aimed at supporting patients in emergency care seeking treatment for Opioid Use Disorder (OUD).

Koligo Therapeutics, Inc. announced the formal introduction of KYSLECEL in the Eastern United States.

Healthy Interactions, a global leader in health education, in collaboration with Merck, known as MSD outside the United States and Canada, today announced the launch of map4health

The American Association of Kidney Patients (AAKP), the nation's oldest and largest, fully independent kidney patient organization announced plans to join patient research efforts for The Kidney Project.

In its fourth year of awarding grants to community organizations that work to strengthen the social safety net in Los Angeles, Cedars-Sinai is donating $5.9 million to programs that address the physical and behavioral health needs of Los Angeles' most vulnerable populations.

Today, Governor Charlie Baker signed into law legislation that will increase the statewide age of sale for tobacco products - including e-cigarettes - from 18 to 21, include e-cigarettes in the smoke-free workplace law, and prohibit the sale of tobacco products in pharmacies.